419 related articles for article (PubMed ID: 19008126)
1. Preclinical development of tissue-engineered vein valves and venous substitutes using re-endothelialised human vein matrix.
Teebken OE; Puschmann C; Breitenbach I; Rohde B; Burgwitz K; Haverich A
Eur J Vasc Endovasc Surg; 2009 Jan; 37(1):92-102. PubMed ID: 19008126
[TBL] [Abstract][Full Text] [Related]
2. Flow-dependent re-endothelialization of tissue-engineered heart valves.
Lichtenberg A; Cebotari S; Tudorache I; Sturz G; Winterhalter M; Hilfiker A; Haverich A
J Heart Valve Dis; 2006 Mar; 15(2):287-93; discussion 293-4. PubMed ID: 16607913
[TBL] [Abstract][Full Text] [Related]
3. Construction of autologous human heart valves based on an acellular allograft matrix.
Cebotari S; Mertsching H; Kallenbach K; Kostin S; Repin O; Batrinac A; Kleczka C; Ciubotaru A; Haverich A
Circulation; 2002 Sep; 106(12 Suppl 1):I63-I68. PubMed ID: 12354711
[TBL] [Abstract][Full Text] [Related]
4. Tissue-engineered blood vessel graft produced by self-derived cells and allogenic acellular matrix: a functional performance and histologic study.
Yang D; Guo T; Nie C; Morris SF
Ann Plast Surg; 2009 Mar; 62(3):297-303. PubMed ID: 19240529
[TBL] [Abstract][Full Text] [Related]
5. Tissue-engineered bioprosthetic venous valve: a long-term study in sheep.
Teebken OE; Puschmann C; Aper T; Haverich A; Mertsching H
Eur J Vasc Endovasc Surg; 2003 Apr; 25(4):305-12. PubMed ID: 12651167
[TBL] [Abstract][Full Text] [Related]
6. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
[TBL] [Abstract][Full Text] [Related]
7. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
[TBL] [Abstract][Full Text] [Related]
8. The influence of endothelial cells on the ECM composition of 3D engineered cardiovascular constructs.
Pullens RA; Stekelenburg M; Baaijens FP; Post MJ
J Tissue Eng Regen Med; 2009 Jan; 3(1):11-8. PubMed ID: 18972581
[TBL] [Abstract][Full Text] [Related]
9. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue.
Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS
Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464
[TBL] [Abstract][Full Text] [Related]
10. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
Engelmayr GC; Sales VL; Mayer JE; Sacks MS
Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
[TBL] [Abstract][Full Text] [Related]
11. Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes.
Baguneid M; Murray D; Salacinski HJ; Fuller B; Hamilton G; Walker M; Seifalian AM
Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):151-7. PubMed ID: 15032735
[TBL] [Abstract][Full Text] [Related]
12. Tissue engineering of vascular grafts: human cell seeding of decellularised porcine matrix.
Teebken OE; Bader A; Steinhoff G; Haverich A
Eur J Vasc Endovasc Surg; 2000 Apr; 19(4):381-6. PubMed ID: 10801371
[TBL] [Abstract][Full Text] [Related]
13. Great saphenous vein sparing surgery by angioscopic valvuloplasty combined with axial transposition of a competent tributary vein--5-year follow-up.
Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
Eur J Vasc Endovasc Surg; 2009 Jan; 37(1):103-8. PubMed ID: 19010068
[TBL] [Abstract][Full Text] [Related]
14. Histological evaluation of tissue-engineered heart valves implanted in the juvenile sheep model: is there a need for in-vitro seeding?
Dohmen PM; da Costa F; Yoshi S; Lopes SV; da Souza FP; Vilani R; Wouk AF; da Costa M; Konertz W
J Heart Valve Dis; 2006 Nov; 15(6):823-9. PubMed ID: 17152791
[TBL] [Abstract][Full Text] [Related]
15. Human umbilical cord cells for cardiovascular tissue engineering: a comparative study.
Kadner A; Zund G; Maurus C; Breymann C; Yakarisik S; Kadner G; Turina M; Hoerstrup SP
Eur J Cardiothorac Surg; 2004 Apr; 25(4):635-41. PubMed ID: 15037283
[TBL] [Abstract][Full Text] [Related]
16. Reendothelialization of tubular scaffolds by sedimentary and rotative forces: a first step toward tissue-engineered venous graft.
Wu YF; Zhang J; Gu YQ; Li JX; Wang LC; Wang ZG
Cardiovasc Revasc Med; 2008; 9(4):238-47. PubMed ID: 18928949
[TBL] [Abstract][Full Text] [Related]
17. A low-flow adaptation phase improves shear-stress resistance of artificially seeded endothelial cells.
Gulbins H; Pritisanac A; Petzold R; Goldemund A; Doser M; Dauner M; Meiser B; Reichart B; Daebritz S
Thorac Cardiovasc Surg; 2005 Apr; 53(2):96-102. PubMed ID: 15786008
[TBL] [Abstract][Full Text] [Related]
18. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
[TBL] [Abstract][Full Text] [Related]
19. Seeding of human vascular cells onto small diameter polyurethane vascular grafts.
Gulbins H; Pritisanac A; Dauner M; Petzold R; Goldemund A; Doser M; Meiser B; Reichart B
Thorac Cardiovasc Surg; 2006 Mar; 54(2):102-7. PubMed ID: 16541350
[TBL] [Abstract][Full Text] [Related]
20. Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques.
Roh JD; Brennan MP; Lopez-Soler RI; Fong PM; Goyal A; Dardik A; Breuer CK
J Pediatr Surg; 2007 Jan; 42(1):198-202. PubMed ID: 17208565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
